J. T. Zhou

Binding of human immunodeficiency virus type 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. National Institutes of Health AIDS Vaccine Clinical Trials Networks.

D. Montefiori, B. Graham, J. Ahearn, 1994, The Journal of infectious diseases.

Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.

D. Montefiori, P. Johnson, V. Hirsch, 1994, Virology.

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.

D. Montefiori, A. Fauci, G. Pantaleo, 1997, The Journal of infectious diseases.

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.

D. Montefiori, A. Fauci, G. Pantaleo, 1996, The Journal of infectious diseases.